Healthcare Startup Laboratoy work visual

We incubate and accelerate therapeutic and therapeutic platform ventures. Since early 2018, BaseLaunch has supported nine ventures that have, in total, raised over 100 million USD in financing. Several pharma collaborations have been initiated and one company has been sold. As of December 2019, we have added another four companies to our portfolio. Furthermore, BaseLaunch has been contributing to the development of six more ventures in the Basel Area (ABBA therapeutics, Alibion, Avicenna Oncology, Captor Therapeutics, FoRx Therapeutics, Sunregen.)

 

During its first phase (2017-2019), BaseLaunch was supported by Roche, Novartis Ventures, J&J, Pfizer and Roivant. Because of our success, in 2020 the second phase has now been launched and the available funding increased to up to 500,000 USD per company. Partners for the second phase will be made public over the coming months.

 

BaseLaunch is managed and operated by Basel Area Business & Innovation, the innovation and investment promotion agency for the Basel Area.

Basel Area: A leading Life Sciences hub

The Basel Area is a biotech hotspot. It is home to Roche and Novartis, two of the world’s largest pharmaceutical companies, as well as Actelion, part of the Johnson & Johnson Family of Companies, and formerly Europe’s biggest biotechs. But it is not just about big pharma, one also finds biotech companies like Idorsia, Roivant Sciences, Galapagos, Anaveon, Basilea, Beigen, Halozyme, Mirum Pharmaceuticals, NBE Therapeutics, Nouscom Polyneuron, Santhera, Skyhawk Therapeutics and many others.

 

Additionally, world-class research institutions such as the D-BSSE branch of the ETH Zürich, the Biozentrum, the Department of Biomedicine of the University of Basel, the Friederich Miescher Institute, the Life Sciences branch of the University of Applied Sciences and more are based here.

 

This tightly interwoven academic and biopharma environment feeds the tremendous innovation power of the Basel Area, ensures a diverse talent base and provides access to financing from marque venture capitalists like the Novartis Venture Fund, Roche Venture Fund, Versant Ventures, BioMedPartners, MTIP, among others. This makes the Basel Area the ideal breeding ground for the creation of new biopharma ventures.

 

BaseLaunch is deeply embedded within this ecosystem, while also being connected to the global biopharma community – and we put both networks to work for the ventures we support.

 

For more information on the Basel region as a business location, please visit BaselArea.swiss.

Biotech Office Buildings